
pulnovomed,帕母医疗
Total raised: $100M
Funding Rounds 1
Date | Series | Amount | Investors |
03.03.2025 | Series C | $100M | - |
Mentions in press and media 3
Date | Title | Description |
03.03.2025 | Pulnovo Medical Closes $100M Series C | Pulnovo Medical, a Shanghai, China-based medtech company developing devices for pulmonary hypertension (PH) and heart failure (HF), raised $100M in Series C funding. The round was led by Qiming Venture Partners and existing shareholder Lill... |
09.07.2024 | Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee | SHANGHAI, July 9, 2024 /PRNewswire/ -- Pulnovo Medical, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure, has recently announced its partnership with the Pulmonary Hypertension Association (... |
09.07.2024 | Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee | SHANGHAI, July 9, 2024 /PRNewswire/ -- Pulnovo Medical, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure, has recently announced its partnership with the Pulmonary Hypertension Association (... |